BR112014008602A2 - composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica - Google Patents

composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica

Info

Publication number
BR112014008602A2
BR112014008602A2 BR112014008602A BR112014008602A BR112014008602A2 BR 112014008602 A2 BR112014008602 A2 BR 112014008602A2 BR 112014008602 A BR112014008602 A BR 112014008602A BR 112014008602 A BR112014008602 A BR 112014008602A BR 112014008602 A2 BR112014008602 A2 BR 112014008602A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
metered dose
dose inhaler
suffer
treating
Prior art date
Application number
BR112014008602A
Other languages
English (en)
Other versions
BR112014008602B1 (pt
Inventor
Corr Stuart
James Noakes Timothy
Original Assignee
Mexichem Amanco Holding Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexichem Amanco Holding Sa filed Critical Mexichem Amanco Holding Sa
Publication of BR112014008602A2 publication Critical patent/BR112014008602A2/pt
Publication of BR112014008602B1 publication Critical patent/BR112014008602B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/003—Adding propellants in fluid form to aerosol containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1 / 1 resumo “composiã‡ãƒo farmacãšutica, recipiente vedado, inalador de dosagem medida, mã‰todos para o tratamento de um paciente que sofre ou provavelmente sofre de um distãšrbio respiratã“rio, e, mã‰todo para fabricaã‡ãƒo de uma composiã‡ãƒo farmacãšutica” uma composiã§ã£o farmacãªutica ã© descrita que ã© adequada pela dispensaã§ã£o de um recipiente pressurizado. a composiã§ã£o ã© livre dos excipientes polares e compreende: (a) um componente propelente que consiste essencialmente de 1,1-difluoroetano (r- 152a); (b) um componente de tensoativo que compreende ã¡cido oleico; e (c) um componente de droga que consiste de sulfato de salbutamol. a composiã§ã£o farmacãªutica pode ser dispensada usando um inalador de dosagem medida (mdi).
BR112014008602-8A 2011-10-12 2012-10-12 Composição farmacêutica, recipiente vedado, inalador de dosagem medida, e, método para fabricação de uma composição farmacêutica BR112014008602B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1117619.5 2011-10-12
GBGB1117619.5A GB201117619D0 (en) 2011-10-12 2011-10-12 Compositions
PCT/GB2012/052544 WO2013054137A1 (en) 2011-10-12 2012-10-12 Compositions comprising salbutamol sulphate

Publications (2)

Publication Number Publication Date
BR112014008602A2 true BR112014008602A2 (pt) 2017-04-18
BR112014008602B1 BR112014008602B1 (pt) 2022-05-24

Family

ID=45091931

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014008602-8A BR112014008602B1 (pt) 2011-10-12 2012-10-12 Composição farmacêutica, recipiente vedado, inalador de dosagem medida, e, método para fabricação de uma composição farmacêutica

Country Status (12)

Country Link
US (2) US9517216B2 (pt)
EP (1) EP2766006B1 (pt)
JP (1) JP5894283B2 (pt)
CN (1) CN103874489B (pt)
AU (1) AU2012322455B2 (pt)
BR (1) BR112014008602B1 (pt)
CA (1) CA2851026C (pt)
ES (1) ES2556586T3 (pt)
GB (1) GB201117619D0 (pt)
MX (1) MX335944B (pt)
WO (1) WO2013054137A1 (pt)
ZA (1) ZA201402321B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201306984D0 (en) * 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
BR122020022602B1 (pt) * 2015-12-04 2024-03-05 Mexichem Fluor S.A. De C.V. Composição farmacêutica
ES2956521T3 (es) * 2016-09-19 2023-12-22 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende bromuro de tiotropio
JP6781830B2 (ja) * 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物
KR102279445B1 (ko) * 2016-09-19 2021-07-22 멕시켐 플루어 소시에다드 아노니마 데 카피탈 바리아블레 약제학적 조성물
ES2877575T3 (es) 2016-09-19 2021-11-17 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende salmeterol
ES2968453T3 (es) 2016-09-19 2024-05-09 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende glicopirrolato
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
GB2584686A (en) * 2019-06-11 2020-12-16 Mexichem Fluor Sa De Cv Methods
FR3130554A1 (fr) 2021-12-20 2023-06-23 Aptar France Sas Composition pharmaceutique comprenant du salbutamol
FR3137830A1 (fr) * 2022-07-13 2024-01-19 Aptar France Sas Composition pharmaceutique comprenant du salbutamol
WO2024033941A1 (en) * 2022-08-10 2024-02-15 Cipla Limited A pharmaceutical composition of salbutamol and pharmaceutical green propellant

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5439670A (en) 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
MX9704550A (es) 1994-12-22 1997-10-31 Astra Ab Formulaciones de medicamentos en aerosol.
EE04004B1 (et) 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Flutikasoonpropionaati doseeriv inhalaator
ATE239447T1 (de) 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
ATE234604T1 (de) 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
GB2392915B (en) 1999-09-11 2004-04-28 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
US6432415B1 (en) 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
CN1144582C (zh) 2000-11-28 2004-04-07 中国药科大学 治疗呼吸系统疾病的无氟里昂药用气雾剂
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0323685D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
CN1559389A (zh) * 2004-03-05 2005-01-05 山东京卫制药有限公司 硫酸左旋沙丁胺醇气雾剂及其制备工艺
WO2006004646A1 (en) 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
WO2007020204A2 (en) 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
CN101428010A (zh) * 2008-12-12 2009-05-13 国家纳米技术与工程研究院 一种硫酸沙丁胺醇细粉的制备方法
GB0915106D0 (en) 2009-08-28 2009-10-07 Glaxo Group Ltd Process

Also Published As

Publication number Publication date
AU2012322455A1 (en) 2014-04-17
GB201117619D0 (en) 2011-11-23
ES2556586T3 (es) 2016-01-19
CN103874489B (zh) 2016-01-20
US20140230812A1 (en) 2014-08-21
JP5894283B2 (ja) 2016-03-23
EP2766006A1 (en) 2014-08-20
US10039828B2 (en) 2018-08-07
BR112014008602B1 (pt) 2022-05-24
EP2766006B1 (en) 2015-11-25
MX335944B (es) 2016-01-04
US20170165367A1 (en) 2017-06-15
WO2013054137A1 (en) 2013-04-18
AU2012322455B2 (en) 2015-07-02
MX2014004279A (es) 2014-05-28
US9517216B2 (en) 2016-12-13
CN103874489A (zh) 2014-06-18
ZA201402321B (en) 2015-03-25
JP2014528470A (ja) 2014-10-27
CA2851026A1 (en) 2013-04-18
CA2851026C (en) 2016-01-05

Similar Documents

Publication Publication Date Title
BR112014008602A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
BR112014008609A2 (pt) composição farmacêutica, recipiente vedado, inalador de dosagem medida, método para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica
BR112015026053A8 (pt) composição farmacêutica, recipiente vedado, inalador dosimetrado, uso de um componente propelente, e, método para fabricação de uma composição farmacêutica
BR112019005133A2 (pt) composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente sofrendo ou susceptível de sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica, para melhoria do desempenho de dispersão em aerossol de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica.
AR079726A1 (es) Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) . composicion farmaceutica.frasco de aerosol. metodo.conjunto de componentes
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
BR112013029202A2 (pt) solução farmacêutica, recipiente selado, inalador de dose medida, método para tratar um paciente que sofre ou que está susceptível a sofrer de um distúrbio respiratório, usos de um propelente, de uma composição farmacêutica, e, de um aparelho de administração de medicamentos que contém uma composição farmacêutica
RS52940B (en) PHARMACEUTICAL FORMULATIONS OF SOLUTION FOR MEASURED DOSES OF PRESSURE INHALATORS
BR112015018252A2 (pt) composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit
BR112014027681A2 (pt) preparações de agentes terapêuticos hidrofóbicos, métodos de fabricação e uso dos mesmos
WO2011141929A3 (en) Aqueous pharmaceutical compositions of fluticasone and olopatadine
BR112018011266A2 (pt) ?composição farmacêutica, recipiente vedado, inalador dosimetrado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica?
WO2012016845A3 (en) Pharmaceutical formulation comprising a phosphodiesterase inhibitor
WO2012107765A3 (en) Particle formulation
JP2014528470A5 (pt)
JP2014530231A5 (pt)
WO2013138628A3 (en) Injectable ibuprofen formulation
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
WO2010090494A3 (ko) 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
WO2008089426A3 (en) Methods and compositions for the delivery of a therapeutic agent
GB201118188D0 (en) Manufacture of medicinal aerosol canisters
PH12014501545A1 (en) Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
WO2013104892A8 (en) Application of high dose compounds via inhalation
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
BRPI0916047A2 (pt) composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/10/2012, OBSERVADAS AS CONDICOES LEGAIS